2022 - 2023 Evaluation of drug-induced kidney injury and examination of its risk factors using big data and meta-analysis
Papers (93):
Atsuhiro Mizushima, Satoru Mitsuboshi, Seiya Kobayashi, Kaori Hara, Yoshiaki Ara, Toshihiko Agatsuma. Evaluation of antibiotic de-escalation based on the DASON criteria by pharmacist-led post-prescription review and feedback: A retrospective study in a medium-sized Japanese hospital. Journal of Infection and Chemotherapy. 2025
Satoru Mitsuboshi, Shungo Imai, Masami Tsuchiya, Hayato Kizaki, Satoko Hori. Accuracy of Diagnostic Coding for Acute Kidney Injury in Japan-Analysis of a Japanese Hospital-Based Database. Pharmacoepidemiology and Drug Safety. 2025. 34. 4
Tomoyuki Ishigo, Kazuaki Matsumoto, Hiroaki Yoshida, Hiroaki Tanaka, Yuta Ibe, Satoshi Fujii, Masahide Fukudo, Hisato Fujihara, Fumihiro Yamaguchi, Fumiya Ebihara, et al. Enhancing result reliability by addressing potential confounding factors. Microbiology Spectrum. 2025. e0149924
Satoru Mitsuboshi, Makoto Morizumi, Shungo Imai, Satoko Hori, Kazumasa Kotake. Association between mineralocorticoid receptor antagonists and kidney harm: A systematic review and meta-analysis of randomized controlled trials. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2025
Satoru Mitsuboshi, Kotaro Hitoshi, Ai Ominato, Teruhisa Kinoshita, Yuka Sugimoto, Ayami Kajiwara-Morita, Motoki Urata, Koji Sato, Toshiyuki Sakamaki. Association between sodium-glucose cotransporter-2 inhibitor and adverse events in patients with moderate to severe chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials. European journal of clinical pharmacology. 2024
JAPANESE SOCIETY OF NEPHROLOGY
, JAPANESE SOCIETY OF CHEMOTHERAPY
, THE PHARMACEUTICAL SOCIETY OF JAPAN
, 日本薬剤師会
, JAPANESE SOCIETY FOR INFECTION PREVENTION AND CONTROL
, 日本病院薬剤師会
, 日本腎臓病薬物療法学会